Minerva Endocrinology · Nov 5, 2026
Improved muscle quality attenuates cardiovascular-kidney-metabolic syndrome risk in non-elderly U.S. adults
By Yao X, Wang Y
BACKGROUND: Cardiovascular-kidney-metabolic (CKM) syndrome is a newly defined systemic disorder involving complex interactions among cardiovascular, kidney, and metabolic systems. The muscle quality index (MQI) comprehensively assesses skeletal muscle through integrating mass, strength, and function; however, its relationship with CKM syndrome remains unclear, thus limiting the development of muscle quality-based risk assessment and personalized prevention strategies. METHODS: We analyzed 1672 adults from National Health and Nutrition Examination Survey (NHANES) 2011-2014. Three MQI parameters were calculated: MQI<inf>arm</inf>, MQI<inf>app</inf>, and MQI<inf>total</inf>. Statistical analyses included logistic regression, subgroup analysis, restricted cubic spline, and advanced machine learning methods. RESULTS: Advanced CKM syndrome participants demonstrated significantly lower MQI values compared to non-CKM and early CKM participants. Logistic regression and restricted cubic spline (RCS) analysis confirmed that higher MQI was inversely associated with the presence of CKM syndrome (P for overall <0.001, P for nonlinear =0.21), with consistent associations across demographic subgroups. Machine learning and Boruta analysis emphasize MQI parameters as a superior discriminatory factor compared to muscle mass or strength alone. CONCLUSIONS: MQI demonstrates a significant inverse association with CKM syndrome across various subgroups. Our findings reveal that MQI is a promising, non-invasive indicator for CKM syndrome risk assessment and highlight the significance of improving muscle quality in CKM prevention strategies.
doi.org/10.23736/s2724-6507.26.04597-5PubMed 42986200Biomarkers